Drug and Medication Analysis & Statistics in France, October 2014 (p3)

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

61-90 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Cinacalcet  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Cinacalcet - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Clevidipine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Clevidipine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Saxagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Saxagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Vildagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Vildagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Nilotinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Nilotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, United States, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, World
Perampanel  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Perampanel - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Orphan Drug Market Access: Payer Insights on the Present and Future

Orphan Drug Market Access: Payer Insights on the Present and Future

  • $ 531
  • Industry report
  • October 2014
  • by Firstword Pharma

Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current ...

  • Industries : Drug and Medication
  • Countries : United States, France, Europe, United Kingdom, Spain, Italy, Germany
Genmed Holding Corp. (Symbol:GENM) SWOT Analysis, Strategy, Revenues and Profits

Genmed Holding Corp. (Symbol:GENM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Netherlands, Luxembourg, Ireland, France, Germany, Belgium
ratiopharm direct GmbH SWOT Analysis, Strategy, Revenues and Profits

ratiopharm direct GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Germany, Spain, Italy, France
Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

Adocia (ADOC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Adocia is a biotechnology company. The company offers insulin therapy and the treatment of the diabetic foot ulcer. Its products include PDGF-BB, BioChaperone Insulins combo based on Glargine, ...

  • Industries : Drug and Medication
  • Countries : France
Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019

Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2014-2019

  • $ 1 500
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Growing numbers of farm and companion animals, increasing use of intensive animal husbandry practices and rising incidence of chronic diseases in animals have propelled the need for better animal healthcare. ...

  • Industries : Drug and Medication
  • Countries : World, France, Europe, Canada, Germany, North America, United States, India, China, Switzerland, Brazil, Mexico, Sweden, Spain, Italy, Japan
Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2014-2019

Global Veterinary Anti-Infectives Market Segmented By Veterinary Disease Types, By Animal Types & By Geography - Trends & Forecasts 2014-2019

  • $ 1 500
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Global market for veterinary anti-infectives is estimated to be worth $4.37 billion in 2014. Expected to grow at a healthy CAGR of 8.5%, the market is set to reach $6.92 billion by 2019. For the past several ...

  • Industries : Drug and Medication
  • Countries : World, France, Canada, Germany, Europe, United States, North America, Switzerland, Mexico, Sweden, Spain, Italy, Japan, India, China
France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: France is one of the leading global pharmaceutical industry s by size, propped up by its large population of just under 63mn. The French are traditionally fond of patented and branded drugs and ...

  • Industries : Drug and Medication
  • Countries : France
Europe Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

Europe Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

  • $ 1 500
  • Industry report
  • August 2014
  • by Mordor Intelligence LLP

Europe is a matured and highly regulated market. Increasing meat consumption, food safety concerns and improving meat prices in the European continent are important drivers for the growth of the anticoccidial ...

  • Industries : Drug and Medication
  • Countries : Europe, World, Spain, France, United Kingdom, Italy, Germany
PharmaPoint: Asthma - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - 5EU Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through ...

  • Industries : Drug and Medication
  • Countries : Spain, France, Italy, Germany, United Kingdom, Europe, World
Flutiform (Asthma) - Forecast and Market Analysis to 2023

Flutiform (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Flutiform (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Flutiform (Asthma) - Forecast and Market Analysis to 2023”. The ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United Kingdom, Europe
Singulair (Asthma) - Forecast and Market Analysis to 2023

Singulair (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Singulair (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Singulair (Asthma) - Forecast and Market Analysis to 2023”. The ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Ginger S.A. - Strategic SWOT Analysis Review

Ginger S.A. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary Ginger S.A. (Ginger) is a civil engineering and construction service provider. It provides research and survey related services to civil engineering and other construction projects. The company ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • July 2014
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, United Kingdom, Europe, World
MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible ...

  • Industries : Drug and Medication
  • Countries : World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in France

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in France

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

In general, consumers are used to self-medicating with products from this category and they did not change their habits in 2010. However, the category faced stronger competition from some homoeopathic ...

  • Industries : Drug and Medication
  • Countries : France
Analgesics Market Analysis in France

Analgesics Market Analysis in France

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

However, there remained a lack of investment within the aspirin category, which partly explains the modest performance of analgesics in 2010. Aspirin continued to be threatened by consumers’ preference ...

  • Industries : Drug and Medication
  • Countries : France
NRT Smoking Cessation Aids Market Analysis in France

NRT Smoking Cessation Aids Market Analysis in France

  • $ 898
  • Industry report
  • June 2014
  • by Euromonitor International

However this legislation, put into force some years ago, seems to have reached its limits in terms of impact, as... Euromonitor International's report offers a comprehensive guide to the size and shape ...

  • Industries : Drug and Medication, Tobacco
  • Countries : France
Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

Mold Inhibitors Market, By Type (Propionates, Sorbates, Benzoates, and Natamycin), By Application (Food, Feed, Paint, Pharmaceuticals, and Cosmetics) - Global Trends & Forecast to 2019

  • $ 4 650
  • Industry report
  • May 2014
  • by MarketsandMarkets

The mold inhibitors market is expected to grow at a CAGR of 2.9% from 2014 to 2019. The estimation is made on the basis of the increasing health awareness among consumers as mold causes allergies, asthma, ...

  • Industries : Drug and Medication
  • Countries : World, North America, Europe, China, Mexico, Canada, India, South Africa, Brazil, France, Germany, Japan, United States
MarketVIEW: Group B Streptococcus

MarketVIEW: Group B Streptococcus

  • $ 4 495
  • Industry report
  • May 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Group B beta streptococci (GBS) or Streptococcus agalactiae is an encapsulated Gram-positive coccus capable of producing a range of diseases in humans of all age ranges. In the neonate, the bacterium can ...

  • Industries : Drug and Medication
  • Countries : United States, World, Australia, Africa, Brazil, Mexico, Canada, United Kingdom, Spain, Italy, France, Germany, Europe, North America
PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • April 2014
  • by Global Data

PharmaPoint: Neuropathic Pain - 5EU Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Italy, Spain, France, Germany, United Kingdom, Europe, World
Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Lyrica (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Nucynta ER/Palexia SR (Neuropathic Pain) - Forecast and Market Analysis to 2022

Nucynta ER/Palexia SR (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Nucynta ER/Palexia SR (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, France, Germany, World, United States, United Kingdom, Europe
Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022

Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive ...

  • Industries : Drug and Medication
  • Countries : Germany, United States, World, Spain, Italy, France, Europe, United Kingdom
Qutenza (Neuropathic Pain) - Forecast and Market Analysis to 2022

Qutenza (Neuropathic Pain) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • April 2014
  • by Global Data

Qutenza (Neuropathic Pain) - Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which ...

  • Industries : Drug and Medication
  • Countries : World, Europe, United States, Spain, Italy, France, Germany, United Kingdom
About 100 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Market in Europe

  • September 2014
    9 pages
  • Drug And Medica...  

    Paracetamol  

  • France  

View report >

Drug Markets In France

November 2013

Drug Markets In France

November 2013

2 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Select Products Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.